Please login to the form below

Not currently logged in
Email:
Password:

Neurodegenerative disease

This page shows the latest Neurodegenerative disease news and features for those working in and with pharma, biotech and healthcare.

Merck & Co signs deal with Amathus for neurodegeneration diseases

Merck & Co signs deal with Amathus for neurodegeneration diseases

Merck &Co has signed a strategic collaboration agreement with Amathus Therapeutics focused on developing novel small molecule candidates for neurodegenerative diseases. ... The Merck neuroscience team is an ideal partner to translate this novel approach

Latest news

More from news
Approximately 2 fully matching, plus 69 partially matching documents found.

Latest Intelligence

  • AI and accelerated computing ring in new era for healthcare AI and accelerated computing ring in new era for healthcare

    A disease pathway – a chain of signals between molecules that trigger different cell functions – may involve thousands of interacting proteins. ... The project is initially connecting four of London’s premier teaching hospitals, offering AI

  • Detecting Alzheimer’s ahead of a cure Detecting Alzheimer’s ahead of a cure

    Yet the effort to find different ways to combat the neurodegenerative disease have not stalled, with researchers looking into the possibility of early detection as a new avenue to explore in ... According to the study, the blood test is able to identify

  • A roadmap to the successful treatment of Alzheimer’s disease A roadmap to the successful treatment of Alzheimer’s disease

    Nevertheless, strategies for developing successful therapeutic interventions are shifting. We have developed a five-point roadmap to successful treatments for Alzheimer’s disease and neurodegenerative diseases. ... Hyper-stimulation of microglial cells

  • Key considerations for disease- modifying Parkinson’s disease trials Key considerations for disease- modifying Parkinson’s disease trials

    The design of such neuroprotective studies may benefit from the lessons learned in studies in the most common neurodegenerative disease, Alzheimer’s. ... Target early disease stages: It is probably true for all neurodegenerative diseases that symptoms

  • Pharma deals during January 2013 Pharma deals during January 2013

    During the option, AZ will continue to research and evaluate OX CLI in respiratory disease (see table 2). ... SMA is an orphan neurodegenerative genetic disease that presents early in life.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • New hires at EMA, Gilead and BeiGene New hires at EMA, Gilead and BeiGene

    Most recently, Grant was chief executive officer of the Dementia Discovery Fund (DDF), a specialist venture capital fund focused on therapeutics for age-related dementias and neurodegenerative disease.

  • Prevail Therapeutics adds to its board of directors Prevail Therapeutics adds to its board of directors

    Francois Nader joins the biotech. Prevail Therapeutics, a biotechnology company focused on the development of gene therapies for patients with neurodegenerative diseases, has strengthened its board of directors with the addition ... The Prevail team has

  • Asceneuron appoints chief medical officer Asceneuron appoints chief medical officer

    Novartis’ Michael Ryan joins the neurodegenerative diseases specialist. Lausanne, Switzerland-based Asceneuron has appointed Michael Ryan as its new chief medical officer. ... His outstanding track record and expertise in neurodegenerative disease are

  • Eisai recruits Pfizer and Sanofi execs to neurology group Eisai recruits Pfizer and Sanofi execs to neurology group

    As global lead for Alzheimer's Disease she will also be tasked with developing strategies and heading internal and external collaborations. . ... Eisai's Cheung said: "With her deep expertise in the commercial development of in-line and

  • Nobel laureate Dr Walter Gilbert joins Amylyx Pharmaceuticals Nobel laureate Dr Walter Gilbert joins Amylyx Pharmaceuticals

    The US-based pharmaceutical firm specialises in developing disease-modifying treatments for neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS). ... Loeb University Professor Emeritus at Harvard University. He said: “Amylyx has

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • The ALS patient journey

    Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND). ... ALS is a progressive neurodegenerative disease, and the fast onset of increasingly severe symptoms after diagnosis can be devastating.

  • Why eating people is wrong (and other medical discoveries)

    The case against cannibalism began with an earlier medical discovery. A neurodegenerative disease known as kuru was found to be common among the Fore people of Papua New Guinea. ... This was later identified as a prion (misfolded protein), and therefore

  • Conference Live: Case study

    The challenge:. Our client was developing a portfolio for the treatment of a chronic neurodegenerative disease and planned to have a significant presence at key neuroscience conferences over the coming year.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....

Infographics